GLAXOSMITHKLINE PHARMACEUTICALS
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr |
| Equity - Authorised | ₹180 Cr | ₹180 Cr | ₹180 Cr | ₹180 Cr | ₹180 Cr |
| Equity - Issued | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr |
| Equity Paid Up | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr | ₹169 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹-16 Cr | ₹-15 Cr | ₹-9.01 Cr | ₹-1.68 Cr | - |
| Total Reserves | ₹2,114 Cr | ₹1,797 Cr | ₹1,617 Cr | ₹1,574 Cr | ₹2,494 Cr |
| Securities Premium | - | - | - | - | - |
| Capital Reserves | ₹-19 Cr | ₹-19 Cr | ₹-19 Cr | ₹-19 Cr | ₹-19 Cr |
| Profit & Loss Account Balance | ₹1,383 Cr | ₹1,059 Cr | ₹876 Cr | ₹829 Cr | ₹1,743 Cr |
| General Reserves | ₹779 Cr | ₹779 Cr | ₹779 Cr | ₹779 Cr | ₹779 Cr |
| Other Reserves | ₹-29 Cr | ₹-21 Cr | ₹-19 Cr | ₹-14 Cr | ₹-8.43 Cr |
| Reserve excluding Revaluation Reserve | ₹2,114 Cr | ₹1,797 Cr | ₹1,617 Cr | ₹1,574 Cr | ₹2,494 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹2,267 Cr | ₹1,951 Cr | ₹1,778 Cr | ₹1,741 Cr | ₹2,663 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-134 Cr | ₹-141 Cr | ₹-146 Cr | ₹-134 Cr | ₹-113 Cr |
| Deferred Tax Assets | ₹175 Cr | ₹168 Cr | ₹163 Cr | ₹152 Cr | ₹132 Cr |
| Deferred Tax Liability | ₹41 Cr | ₹27 Cr | ₹17 Cr | ₹18 Cr | ₹19 Cr |
| Other Long Term Liabilities | ₹17 Cr | ₹2.49 Cr | ₹6.57 Cr | ₹4.14 Cr | ₹9.68 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹260 Cr | ₹249 Cr | ₹247 Cr | ₹255 Cr | ₹262 Cr |
| Total Non-Current Liabilities | ₹144 Cr | ₹111 Cr | ₹108 Cr | ₹125 Cr | ₹159 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹570 Cr | ₹708 Cr | ₹625 Cr | ₹428 Cr | ₹579 Cr |
| Sundry Creditors | ₹570 Cr | ₹708 Cr | ₹625 Cr | ₹428 Cr | ₹579 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹244 Cr | ₹256 Cr | ₹207 Cr | ₹185 Cr | ₹504 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹58 Cr | ₹6.61 Cr | ₹7.55 Cr | ₹7.08 Cr | ₹4.35 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹186 Cr | ₹249 Cr | ₹200 Cr | ₹178 Cr | ₹499 Cr |
| Short Term Borrowings | - | - | - | - | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | - | - | - |
| Short Term Provisions | ₹965 Cr | ₹941 Cr | ₹692 Cr | ₹714 Cr | ₹615 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹546 Cr | ₹525 Cr | ₹299 Cr | ₹296 Cr | ₹296 Cr |
| Provision for post retirement benefits | ₹4.88 Cr | ₹5.01 Cr | ₹4.78 Cr | ₹4.48 Cr | ₹3.42 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹414 Cr | ₹411 Cr | ₹389 Cr | ₹413 Cr | ₹316 Cr |
| Total Current Liabilities | ₹1,779 Cr | ₹1,905 Cr | ₹1,525 Cr | ₹1,326 Cr | ₹1,698 Cr |
| Total Liabilities | ₹4,190 Cr | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr |
| ASSETS | |||||
| Gross Block | ₹716 Cr | ₹667 Cr | ₹663 Cr | ₹634 Cr | ₹592 Cr |
| Less: Accumulated Depreciation | ₹436 Cr | ₹384 Cr | ₹343 Cr | ₹305 Cr | ₹262 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹280 Cr | ₹283 Cr | ₹320 Cr | ₹329 Cr | ₹329 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹33 Cr | ₹14 Cr | ₹14 Cr | ₹20 Cr | ₹31 Cr |
| Non Current Investments | ₹0.87 Cr | - | - | - | - |
| Long Term Investment | ₹0.87 Cr | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | ₹0.87 Cr | - | - | - | - |
| Long Term Loans & Advances | ₹269 Cr | ₹259 Cr | ₹275 Cr | ₹347 Cr | ₹445 Cr |
| Other Non Current Assets | ₹0.26 Cr | ₹0.46 Cr | ₹1.24 Cr | ₹1.10 Cr | ₹5.45 Cr |
| Total Non-Current Assets | ₹584 Cr | ₹557 Cr | ₹612 Cr | ₹699 Cr | ₹812 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹1,391 Cr | ₹1,118 Cr | ₹813 Cr | ₹518 Cr | ₹366 Cr |
| Quoted | ₹1,391 Cr | ₹1,118 Cr | ₹813 Cr | ₹518 Cr | ₹366 Cr |
| Unquoted | - | - | - | - | - |
| Inventories | ₹458 Cr | ₹482 Cr | ₹525 Cr | ₹460 Cr | ₹535 Cr |
| Raw Materials | ₹93 Cr | ₹113 Cr | ₹107 Cr | ₹104 Cr | ₹107 Cr |
| Work-in Progress | ₹1.56 Cr | ₹0.94 Cr | ₹0.81 Cr | ₹0.95 Cr | ₹0.88 Cr |
| Finished Goods | ₹125 Cr | ₹113 Cr | ₹99 Cr | ₹101 Cr | ₹151 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹1.10 Cr | ₹0.85 Cr | ₹4.00 Cr | ₹3.85 Cr | ₹3.88 Cr |
| Other Inventory | ₹237 Cr | ₹254 Cr | ₹314 Cr | ₹250 Cr | ₹272 Cr |
| Sundry Debtors | ₹273 Cr | ₹293 Cr | ₹222 Cr | ₹192 Cr | ₹205 Cr |
| Debtors more than Six months | ₹20 Cr | ₹18 Cr | ₹16 Cr | ₹17 Cr | ₹26 Cr |
| Debtors Others | ₹271 Cr | ₹291 Cr | ₹220 Cr | ₹188 Cr | ₹200 Cr |
| Cash and Bank | ₹1,391 Cr | ₹1,404 Cr | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr |
| Cash in hand | - | - | - | - | - |
| Balances at Bank | ₹1,391 Cr | ₹1,404 Cr | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹57 Cr | ₹87 Cr | ₹150 Cr | ₹155 Cr | ₹89 Cr |
| Interest accrued on Investments | ₹14 Cr | ₹8.95 Cr | ₹9.01 Cr | ₹14 Cr | ₹7.64 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹19 Cr | ₹19 Cr | ₹21 Cr | ₹15 Cr | ₹14 Cr |
| Other current_assets | ₹24 Cr | ₹60 Cr | ₹121 Cr | ₹126 Cr | ₹68 Cr |
| Short Term Loans and Advances | ₹37 Cr | ₹26 Cr | ₹25 Cr | ₹12 Cr | ₹28 Cr |
| Advances recoverable in cash or in kind | ₹12 Cr | ₹5.45 Cr | ₹9.18 Cr | ₹7.84 Cr | ₹19 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹24 Cr | ₹21 Cr | ₹16 Cr | ₹4.38 Cr | ₹9.73 Cr |
| Total Current Assets | ₹3,606 Cr | ₹3,410 Cr | ₹2,798 Cr | ₹2,494 Cr | ₹3,708 Cr |
| Net Current Assets (Including Current Investments) | ₹1,827 Cr | ₹1,505 Cr | ₹1,273 Cr | ₹1,168 Cr | ₹2,009 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹4,190 Cr | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr |
| Contingent Liabilities | ₹515 Cr | ₹456 Cr | ₹387 Cr | ₹354 Cr | ₹355 Cr |
| Total Debt | - | - | - | - | - |
| Book Value | 134.77 | 116.06 | 105.47 | 102.89 | 157.19 |
| Adjusted Book Value | 134.77 | 116.06 | 105.47 | 102.89 | 157.19 |
Compare Balance Sheet of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹39,518.5 Cr | 9.8% | -0.6% | -31.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 9.8% |
-0.6% |
-31.3% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses